Sign in

CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company

4D Molecular Therapeutics, Inc.

Sign in to watch
Ticker
FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473506994
Phone
5105052680
Business address
5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Former names
4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
  1. 144 Insider Sale of Securities
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. EFFECT Other Notice of Effectiveness
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. UPLOAD Other SEC-generated Letter
  8. S-3 Offering Registration Statement
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. ARS Other Annual Report to Security Holders
  12. DEFA14A Proxy Proxy Materials
  13. DEF 14A Proxy Proxy Statement
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 8-K Event Executive or director change
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. 4 Open-market sale VP, Finance and Controller sold 390 shares at $8.61 ($3,358)

Page 3 of 22 · 440 filings